Old Web
English
Sign In
Acemap
>
Paper
>
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
2015
Mark R. Rigby
Kristina M. Harris
Ashley Pinckney
Linda A. DiMeglio
Marc Rendell
Eric I. Felner
Jean M. Dostou
Stephen E. Gitelman
Kurt J. Griffin
Eva Tsalikian
Peter A. Gottlieb
Carla J. Greenbaum
Nicole A. Sherry
Wayne V. Moore
Roshanak Monzavi
Steven M. Willi
Philip Raskin
Lynette Keyes-Elstein
S. Alice Long
Sai Kanaparthi
Noha Lim
Deborah Phippard
Carol L. Soppe
Margret L. Fitzgibbon
James McNamara
Gerald T. Nepom
Mario R. Ehlers
Keywords:
Dermatologic agents
Pharmacotherapy
Type 1 diabetes
Immunology
Alefacept
Medicine
Internal medicine
Immunologic memory
Diabetes mellitus
new onset
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]